Mr. Kerner has played a major role in some of the most hotly-contested and high-profile mass torts and MDLs in the past 20 years. In the area of pharmaceuticals, Mr. Kerner has litigated mass torts and MDLs involving alendronate, where he was appointed by the Federal Judge as liaison counsel for the generic pharmaceutical defendants, amiodarone, metoclopramide, pamidronate, propofol, PPA and the diet drug fen-phen. Other mass torts and MDLs in which Mr. Kerner has been actively involved include ephedra, natural rubber latex gloves, orthopedic bone screws and semiconductor clean rooms. He has successfully litigated individual cases concerning various consumer products, as well as pharmaceuticals and orthopedic medical devices. Mr. Kerner has acted as lead trial counsel in cases across multiple industries and jurisdictions. In his role as national counsel, Mr. Kerner supervises local counsel and is responsible for coordinating and maintaining a consistent litigation strategy on a nationwide basis. He works closely with a national network of medical, scientific, regulatory and industry experts in preparation for trials and Daubert hearings.
Mr. Kerner also provides strategic counseling to clients on litigation avoidance and risk management in various industries. He advises clients on labeling and warnings issues, including regulatory compliance.
Mr. Kerner is the Chair of the Food Law Special Litigation Group of the Defense Research Institute (DRI) Product Liability Committee and is the Past Chair of the Class Action and Mass Tort Special Litigation Group of the DRI's Product Liability Committee. He also serves on DRI’s Product Liability Steering Committee and is also the Chair of the firm’s Nanotechnology Practice.